Drug Trial Radar · NCT05265325
A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis
Last checked: Nov 19, 2026Latest source record: Jun 28, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
175
Actual
Start
May 3, 2023
Primary completion
Feb 29, 2024
Study completion Apr 25, 2024
Sponsor
- Lead sponsor
- Kind Pharmaceuticals LLCIndustry
- Sponsor type
- Industry
- First posted
- Mar 3, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase II study to evaluate the safety and efficacy of AND017 in renal anemia patients on dialysis
Conditions
- Renal Anemia
Interventions
AND017 capsules TIWDrug
Orally, 3 times per week in Period 1 and dose adjustment in Period 2 at 2 mg/4 mg and 2-weeks interval according to Hb levels
AND017 capsules QWDrug
Orally, once per week in Period 1 and dose adjustment in Period 2 at 4 mg/8 mg and 2-weeks interval according to Hb levels
epoetin alfa, darbepoetin alfa, Mircera®, or their biosimilarsDrug
Dose regimen and adjustment rules according to the USPI or SmPC or local practice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of adverse eventsTime frame: Up to 20 weeks
- Mean change from baseline in Hb at Week 6Time frame: Up to 5 weeks after dosing
Locations
25 sites in 2 countries. Site status is shown where the registry gives one.
US Renal Care - Pine Bluff
Pine Bluff, Arkansas
North America Research Institute
Riverside, California
Rocky Mountain Kidney Care
Lone Tree, Colorado
Nephrology and Hypertension Specialists
Dalton, Georgia
High Desert Nephrology Associates
Gallup, New Mexico
Nephrology Associates of Western New York
Cheektowaga, New York
Nephrology Consultants of Northwest Ohio - Toledo
Toledo, Ohio
South Texas Renal Care Group - San Saba
San Antonio, Texas
Clinical Advancement Center PLLC
San Antonio, Texas
South Texas Renal Care Group
San Antonio, Texas
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China
Xiamen Branch, Zhongshan hospital affilicated to Fudan University
Xiamen, Fujian, China
Xiamen Fifth Hospital
Xiamen, Fujian, China
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
Renmin Hospital of Wuhan University
Wuhan, Hunan, China
The First People's Hospital of Changzhou
Changzhou, Jiangsu, China
Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
The Affiliated Zhongshan Hospital of Dalian University
Dalian, Liaoning, China
Zhongshan Hospital affiliated to Fudan University
Shanghai, Shanghai Municipality, China
Jinshan Hospital Affiliated to Fudan University
Shanghai, Shanghai Municipality, China
First Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi, China
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
Zigong First People's Hospital
Zigong, Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.